CVS Caremark to pay $95M in Medicare fraud case A federal judge ruled in favor of a whistleblower, finding CVS’ pharmacy benefit manager Caremark overbilled Medicare for generic drugs.

CVS Health's pharmacy benefit manager unit must pay the U.S. government $95 million after a federal judge found it ...

Medicare is investigating reports that CVS Caremark Corp., the country’s second-largest drugstore chain, has refilled prescriptions and submitted insurance claims without patients’ approval ...

The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...

An unsealed 2014 lawsuit by an Aetna actuary whistleblower against CVS Caremark, the insurer's pharmacy benefit manager, accuses the PBM of billing the government for prescription drugs at a greater ...

CVS Health’s pharmacy benefit manager, Caremark, has been ordered to pay $95 million for overbilling Medicare Part D drug reimbursements, a federal judge ruled Wednesday — a decision that ...

CVS must pay the government at least $95 million after a federal court ruled in favor of a whistleblower, finding its pharmacy benefit subsidiary Caremark overcharged Medicare for generic drugs.

CVS Caremark to pay $95M in Medicare fraud case. Sydney Halleman . Thu, Jun 26, 2025, 5:16 AM 2 min read. In This Article: CVS . This story was originally published on Healthcare Dive.